Agoracom: Small Cap Investment - Zenith Epigenetics - Re: AGM

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

fouremm

Rank: President [?]

Points: 3330 [?]

Votes: 34 Score: 3.8 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: AGM - High Level Summary

in response to

Re: AGM - High Level Summary

fouremm

posted on Jan 08, 2016 12:06AM

One additional note, if/when the new Zenith goes public, ZCC shareholders will directly receive shares in the public co on a pro rata basis

3 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply